news CRISPR/Cas9 shown to limit impact of certain parasitic diseases Researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis… 16 January 2019 | By Drug Target Review Researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection...